Biologically Targeted Cancer Therapy and Marginal Benefits: Are We Making Too Much of Too Little or Are We Achieving Too Little by Giving Too Much?
Year: 2010
Type: article
Source: Clinical Cancer Research
Authors: Tito Fojo, David R. Parkinson
Institutions: Center for Cancer Research, Nodality (United States)
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2160040079
